Beta-Alanine
Of 2,559 on-market beta-alanine products in the January 2026 DSLD dump, the median declared dose is 2,000 mg, and 56.6% list unspecified/undisclosed form as the primary form.
Form share
Of 2,557 products with an identifiable primary form, here is the share held by each form of Beta-Alanine on the market today.
Embed this chart
Free to embed on your site or article — attribution and a link back are built into the frame.
| Form | Quality tier | n | Share |
|---|---|---|---|
| unspecified/undisclosed form | Unrated | 1,447 | 56.6% |
| CarnoSyn Beta-Alanine (branded) | Unrated | 1,107 | 43.3% |
| Beta-Alanine Ethyl Ester Hydrochloride | Unrated | 3 | 0.1% |
Forms we recognize but found no primary-form products for in this release: Beta-Alanine Hydrochloride.
Form share over time
Entry-year breakdown of the top forms, 2012–2025.
Dose distribution
Deciles of declared dose per serving (mg), among 1,828 products with a disclosed amount.
Embed this chart
Free to embed on your site or article — attribution and a link back are built into the frame.
- 6.7% of products fall below the fairy-dust threshold (800 mg, 20% of the studied low dose).
- 28.0% of products don't disclose an amount because Beta-Alanine is declared inside a proprietary blend.
Where does your dose rank?
Enter a per-serving dose (mg) to see exactly how it compares to the 1,828 on-market beta-alanine products with a disclosed amount. The chart above groups doses into deciles; this looks up the exact percentile for one number.
By dosage form
By target group
Top brands
Search interest over time
How often people search for beta-alanine on Google, US only, the last 5 years. This is public interest, not DSLD label data — a spike here doesn't necessarily line up with anything on this page, and Google's own index (100 = that term's peak popularity in the chosen window) is relative, not an absolute search-volume count.
Or see this search directly on trends.google.com.
Forms explained
Label discloses only "Beta-Alanine" with no salt or source form.
Branded source of the same molecule used in many studies; no study compared it with unbranded beta-alanine. No head-to-head human bioavailability or efficacy comparison of this form was located in PubMed searches.
Elemental fraction: 71.0% (C3H7NO2 x HCl, 1:1 (89.09 / 125.55))
No head-to-head human bioavailability or efficacy comparison of this form was located in PubMed searches.
No head-to-head human bioavailability or efficacy comparison of this form was located in PubMed searches.
Reference values
- RDA (adult): not established — Non-proteinogenic, non-essential amino acid made endogenously; no RDA/AI exists.
- Tolerable Upper Intake Level (adult): not established — No UL established. ISSN position stand (Trexler ET et al. 2015, J Int Soc Sports Nutr 12:30, PMID 26175657): appears safe in healthy populations at recommended doses; the only reported side effect is paraesthesia (tingling), attenuated by divided doses of ~1.6g or a sustained-release formula.
- Studied clinical dose range: 4000–6000 mg
- Trexler ET et al. 2015 (ISSN position stand), J Int Soc Sports Nutr 12:30, PMID 26175657 -- 4 weeks of 4-6g/day significantly raises muscle carnosine; 2-4+ weeks of 4-6g/day improves exercise performance, most clearly in 1-4 minute efforts. Corroborated by Saunders B et al. 2017, Br J Sports Med 51(8):658-669, PMID 27797728 -- meta-analysis of 40 placebo-controlled studies (1,461 participants), overall effect size 0.18 (95% CI 0.08-0.28), larger for 0.5-10 minute exercise capacity; total beta-alanine ingested did not moderate the effect.
- Note: Benefit is cumulative (muscle carnosine loading over weeks), so a single-serving label dose is not directly comparable to the 4-6g/day studied range unless servings per day are known. Not the same compound as L-alanine or phenylalanine (the many phenylalanine/alanine rows in DSLD are not matched). A sustained-release vs rapid-release comparison (n=39, 6g/day x28 days) found only the sustained-release form significantly raised muscle carnosine vs placebo and caused less paraesthesia (Varanoske AN et al. 2019, Amino Acids 51(1):49-60, PMID 30003336), but DSLD labels almost never declare release type, so it is not modeled as a form.